| __timestamp | PTC Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 72471000 |
| Thursday, January 1, 2015 | 82080000 | 89204000 |
| Friday, January 1, 2016 | 97130000 | 106010000 |
| Sunday, January 1, 2017 | 121271000 | 137905000 |
| Monday, January 1, 2018 | 153548000 | 159888000 |
| Tuesday, January 1, 2019 | 202541000 | 158425000 |
| Wednesday, January 1, 2020 | 245164000 | 200677000 |
| Friday, January 1, 2021 | 285773000 | 304759000 |
| Saturday, January 1, 2022 | 325998000 | 377221000 |
| Sunday, January 1, 2023 | 332540000 | 336361000 |
Unlocking the unknown
In the competitive landscape of biopharmaceuticals, understanding financial trends is crucial. Over the past decade, from 2014 to 2023, PTC Therapeutics, Inc. and Supernus Pharmaceuticals, Inc. have shown significant shifts in their Selling, General, and Administrative (SG&A) expenses. PTC Therapeutics started with a modest $44.82 million in 2014, growing to $332.54 million by 2023, marking a staggering increase of over 640%. Meanwhile, Supernus Pharmaceuticals began at $72.47 million, reaching $336.36 million in the same period, reflecting a 364% rise. Notably, Supernus surpassed PTC in 2021, with a peak SG&A expense of $377.22 million in 2022. These trends highlight the dynamic nature of financial management in the pharmaceutical industry, where strategic investments in administration and sales can drive growth and competitive advantage.
Comparing SG&A Expenses: Novo Nordisk A/S vs PTC Therapeutics, Inc. Trends and Insights
Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
AbbVie Inc. vs PTC Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Zoetis Inc. vs Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and PTC Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Vericel Corporation
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or HUTCHMED (China) Limited
Amicus Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Supernus Pharmaceuticals, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared